On the morning of October 14, 2020, the 40th anniversary celebration of the establishment of the Shenzhen Special Economic Zone was held in Qianhai, Shenzhen, attended by Xi Jinping, General Secretary of the CPC Central Committee, President of the State Council and Chairman of the Central Military Commission.
also attended by relevant party and state and local leaders, 40 innovative and entrepreneurial figures and advanced role models on the 40th anniversary of the establishment of the Shenzhen Special Economic Zone, and representatives of the builders of the Special Administrative Regions in various industries.
Lu Xianping, Chairman of the Board of Directors of the Memorial Photo Microcore Bio, was invited to attend the celebration as the only entrepreneur and scientist in the biomedicine field among the 40 people honored in the 40 years since the establishment of the SAR.
This honor is not only a recognition of the company's founder, Dr. Lu Xianping, but also an affirmation of the outstanding contribution of microcore organisms in the field of original innovative pharmaceutical research and development, and also a high expectation for the innovation and development of Shenzhen biomedicine and large health industry.
Honorary Certificate 40 years 40 people recognized the person (third from left is Dr. Lu Xianping) General Secretary highly praised the establishment of the Shenzhen Special Economic Zone 40 years of outstanding achievements, he put forward: "Shenzhen is the reform and opening up after the Party and the people created a new city, socialism with Chinese characteristics on a piece of white paper wonderful interpretation."
the vast number of cadres in Shenzhen put on thorns, hard work, with 40 years to go through some of the international metropolises a hundred years to complete the course.
is Chinese miracle in the history of the development of the world created by the Chinese people.
" General Secretary delivered an important speech the original innovative drug research and development is a high-risk, high-input, long-term work, known as the pharmaceutical industry "the jewel in the crown", the need to have multidisciplinary, multi-disciplinary science and management capabilities, is the life of many entrepreneurs will be difficult to realize the dream.
With scientific foresight and two decades of unremitting efforts, Dr. Lu Xianping has developed China's first original chemical new drug with a new mechanism of action, realized the global development of China's original research products, won the respect of the world for Chinese researchers, won honor for the country, and won benefits for people's health.
General Secretary has pointed out that the core technology with independent intellectual property rights is the "life gate" of enterprises.
As the first batch of scientists to return to China to start a business in the field of biomedicine, Dr. Lu Xianping and his team used their knowledge and rich experience in the research and development industry of new drugs to integrate the cutting-edge technologies of pharmaceutical chemistry, genomics, molecular biology and informatics on the basis of new advances and new technologies in the field of life sciences and new drug research and development, and took the lead in building an international advanced "integrated drug discovery and early evaluation platform based on chemical genomics" in China, making the key technologies in the field of new drug research and development in China begin to look at the world level.
With this core technology system and established large database of chemical genomics, the leading compounds with the best comprehensive indicators can be found and screened for follow-up development, reducing the great risk of clinical development and improving the efficiency and success rate of new drug research and development.
this basis, in 2014, Dr. Lu Xianping led the microcore team to successfully develop China's first original anti-tumor chemical new drug Sidabenamine, filling the gap in the field of treatment of T-cell lymphoma outside China.
In November 2019, new adaptations to the treatment of breast cancer were approved, which is the first time in the world that HDAC inhibitors, in combined with other targeted drugs, have been proven to be effective in improving tumor resistance and further increasing the effectiveness of targeted drugs, providing new and effective treatments for cancer patients in urgent need of treatment.
2006, Dr. Lu led a team of scientists to achieve China's first original innovative drug Sidabenamine invention patent overseas patent licensing, creating a Chinese pharmaceutical companies to the United States and other developed countries patent licensing.
October 2020, Siddamine submitted its first application for the market for a new drug for the treatment of adult T-cell leukemia in Japan.
In addition to Siddamine, Dr. Lu's microcore biology has successfully developed a series of new molecular entities such as Sigritamine, Theoroni, CS12192 and other innovative pharmaceutical products with novel mechanisms, covering a number of major diseases such as tumors, metabolic diseases and autoimmune diseases.
Sidabenamine tablets stand at a new historical starting point, the General Secretary of Shenzhen's future development put forward six requirements, covering innovative talent, comprehensive reform, expansion of opening up, urban governance, public health, Guangdong, Hong Kong and Macao, the construction of the Great Bay Area, which is the Party Central Committee to Shenzhen's historical mission.
Shenzhen is a miracle of innovation and development, a highly market-oriented development environment, tolerance of failure of the innovative culture atmosphere and efficient transformation mechanism of scientific and technological achievements, for high-tech enterprises to innovate to provide a perfect growth nutrients.
said: "Innovation is the first driving force, enterprises to win the initiative in the global scientific and technological revolution and industrial change."
microcore biology is a pioneer and leader in the field of research and development of china's original innovative drugs, and the 20 years that Shenzhen Special Administrative Region has gone through together have not only witnessed the historical changes of Shenzhen's reform and opening-up, but also participated in the creation of the great miracle of the Special Administrative Region.
40 years of magnificent, the new journey is inspiring.
The future micro-core organisms will continue to overcome difficulties under the leadership of Dr. Lu, develop more innovative drugs that people can afford, and strive for the innovation and development of the motherland's pharmaceutical industry, in order to achieve the "Healthy China 2030" ambitious goal put forward by General Secretary Xi Jinping to provide Shenzhen samples, for Shenzhen to create a new and greater miracle to make the world look amazing!